Funded by the UK ExCALIBUR H&ES exascale programme, since early 2022 we have provided a RISC-V testbed for HPC to offer free access for scientific software developers to experiment with RISC-V for their workloads. Based upon our experiences of providing access to RISC-V for the HPC community, and our involvement with the RISC-V community at large, in this extended abstract we summarise the current state of RISC-V for HPC and consider the high priority areas that should be addressed to help drive adoption.
No takes yet. Share an insight, caveat, or question.
Nick Brown (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: